FIELD: medicine.
SUBSTANCE: invention concerns medicine, in particular to cardiology. For realisation of the method of diagnostics of essential arterial hypertensia stages size of entropy of system of hydration of formulated elements of blood of the patient is defined. At its value equal 0.911 and lower, determine I stage of an arterial hypertensia. At its value within 0.912-0.953 - about II stage. At value equal 0.954 and above - about III stage of disease.
EFFECT: increase of informativeness and simplification of differential diagnostics of stages of an arterial hypertensia that allows applying a method as the screening-test at inspection of a considerable quantity of patients.
1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DIAGNOSING ARTERIAL HYPERTENSION | 2003 |
|
RU2261442C2 |
METHOD FOR IMMUNE CORRECTION IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION | 2011 |
|
RU2463050C1 |
PREDICTION METHOD OF ARTERIAL HYPERTENSION COMORBIDE FORM AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE DEVELOPMENT | 2016 |
|
RU2620566C1 |
DIABETES DIAGNOSTIC TECHNIQUE | 2009 |
|
RU2405148C2 |
METHOD OF THE DIFFERENTIAL DIAGNOSIS OF ARTERIAL HYPERTENSION IN CHRONIC GLOMERULONEPHRITIS AND STAGE III ESSENTIAL ARTERIAL HYPERTENSION COMPLICATED BY CHRONIC KIDNEY DISEASE | 2022 |
|
RU2801045C1 |
METHOD FOR PREDICTING THE FLOW OF PULMONARY HYPERTENSION IN PATIENTS WITH INBORN HEART FAILURES | 2004 |
|
RU2281033C2 |
METHOD OF DIAGNOSING AFFECTION OF KIDNEYS IN CHILDREN | 2011 |
|
RU2457787C1 |
METHOD FOR PREDICTING CEREBRAL NEOPLASMS | 2004 |
|
RU2253869C1 |
METHOD FOR DETERMINING THE RISK OF DEVELOPING CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH STAGE II ESSENTIAL ARTERIAL HYPERTENSION WITHIN 12 MONTHS AFTER COVID-19 | 2021 |
|
RU2767624C1 |
DIAGNOSTIC TECHNIQUE FOR BRONCHIAL ASTHMA | 2008 |
|
RU2372621C1 |
Authors
Dates
2009-03-27—Published
2008-02-26—Filed